Trial intelligence / Profile preview

ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

NCT07403630Recruiting

Sponsor
Azienda Ospedaliero-Universitaria di Parma
Start
May 2023
Primary completion
Feb 2027
Countries
1
01

Overview

Single-arm trial, sponsored by Azienda Ospedaliero-Universitaria di Parma. Primary endpoint: Rate of change in therapeutic indication of disease from standard-of-care. Started May 2023; status: recruiting.

Beyond the preview

Go deeper on NCT07403630.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07403630.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call